Literature DB >> 2143438

Multiple suppressive effects of transforming growth factor beta 1 on the immune response in chickens.

P Quere1, G J Thorbecke.   

Abstract

The immunosuppressive effect of human recombinant TGF-beta 1 on chicken immune responses in vitro was evaluated. TGF-beta 1 at 1-10 ng/ml reduced T cell proliferation in response to concanavalin A by 50-80% and B cell proliferation in response to LPS by greater than 90%. In contrast, when added to immune spleen cells, it reduced the secondary PFC response to sheep erythrocytes by less than 50%, particularly when added at the same time as antigen on Day 2 of incubation. When TGF-beta 1 was added during a 2-day incubation to nylon wool-nonadherent immune or normal spleen cells, it caused the maintenance and/or appearance of suppressor cells. These suppressor cells, in coculture with immune spleen cells, inhibited the secondary PFC response in vitro without any further exposure to TGF-beta 1. The phenotype of the cells giving rise to suppressor cells under the influence of TGF-beta 1 was CT8+, TCR2+(alpha,beta), CT4-, TCR1-(gamma,delta) cells. The results suggest that, in addition to direct suppressive effects on the proliferation of B cells and of some T cells, TGF-beta 1 may suppress immune responses by maintaining or by promoting the development of suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143438     DOI: 10.1016/0008-8749(90)90221-c

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Construction of a microarray specific to the chicken immune system: profiling gene expression in B cells after lipopolysaccharide stimulation.

Authors:  Aimie J Sarson; Leah R Read; Hamid R Haghighi; Melissa D Lambourne; Jennifer T Brisbin; Huaijun Zhou; Shayan Sharif
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

2.  Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.

Authors:  A P Kuruvilla; R Shah; G M Hochwald; H D Liggitt; M A Palladino; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

3.  Transforming growth factor-beta (TGF beta) inhibition of Epstein-Barr virus (EBV)- and interleukin-4 (IL-4)-induced immunoglobulin production in human B lymphocytes.

Authors:  K P Machold; D A Carson; M Lotz
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

4.  Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

Authors:  L Z Chen; G M Hochwald; C Huang; G Dakin; H Tao; C Cheng; W J Simmons; G Dranoff; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  Minimally activated CD8 autoreactive T cells specific for IRBP express a high level of Foxp3 and are functionally suppressive.

Authors:  Yong Peng; Hui Shao; Yan Ke; Ping Zhang; Gencheng Han; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

6.  Effect of anti-CD3/anti-CD28/interleukin-2 stimulation of mononuclear cells on transforming growth factor beta inhibition of lymphokine-activated killer cell generation.

Authors:  J Koberda; E A Grimm; R P Moser
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

7.  Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice.

Authors:  G J Thorbecke; R Shah; C H Leu; A P Kuruvilla; A M Hardison; M A Palladino
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells.

Authors:  J D Gray; M Hirokawa; D A Horwitz
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.